Pattern of planned systemic therapy usage in newly diagnosed, nonmetastatic squamous cell carcinoma of the head and neck in a commercially insured population in the United States

ConclusionAmong commercially insured patients with newly diagnosed, nonmetastatic SCCHN, the choice of systemic therapy in initial treatment plans was not significantly different between academic centers and community practices. Clinical trials are underutilized and should be encouraged.

Source: Head and Neck - November 13, 2018 Category: ENT & OMF Authors: Jong Chul Park, Christine G. Gourin, Ana P. Kiess, Ranee Mehra, Arlene A. Forastiere, Hyunseok Kang Tags: ORIGINAL ARTICLE Source Type: research